These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1. Overall CM J Cell Physiol; 1995 Jul; 164(1):17-25. PubMed ID: 7790389 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibition in periodontal treatment. Ryan ME; Ramamurthy S; Golub LM Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573 [TBL] [Abstract][Full Text] [Related]
5. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853 [TBL] [Abstract][Full Text] [Related]
6. Regulation of gelatinase-A (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by Transforming Growth Factor-beta(1)and insulin like growth factor-I. Pattison ST; Melrose J; Ghosh P; Taylor TK Cell Biol Int; 2001; 25(7):679-89. PubMed ID: 11448107 [TBL] [Abstract][Full Text] [Related]
7. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Reynolds JJ Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940 [TBL] [Abstract][Full Text] [Related]
8. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Okada Y; Naka K; Kawamura K; Matsumoto T; Nakanishi I; Fujimoto N; Sato H; Seiki M Lab Invest; 1995 Mar; 72(3):311-22. PubMed ID: 7898050 [TBL] [Abstract][Full Text] [Related]
9. Cytoskeleton regulates expression of genes for transforming growth factor-beta 1 and extracellular matrix proteins in dermal fibroblasts. Varedi M; Ghahary A; Scott PG; Tredget EE J Cell Physiol; 1997 Aug; 172(2):192-9. PubMed ID: 9258340 [TBL] [Abstract][Full Text] [Related]
10. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Overall CM; Wrana JL; Sodek J Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843 [TBL] [Abstract][Full Text] [Related]
12. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils. Davoli MA; Lamplugh L; Beauchemin A; Chan K; Mordier S; Mort JS; Murphy G; Docherty AJ; Leblond CP; Lee ER Dev Dyn; 2001 Sep; 222(1):71-88. PubMed ID: 11507770 [TBL] [Abstract][Full Text] [Related]
13. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies. Reynolds JJ; Meikle MC J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805 [TBL] [Abstract][Full Text] [Related]
14. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Fujiwara M; Muragaki Y; Ooshima A Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739 [TBL] [Abstract][Full Text] [Related]
15. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Dittmann KH; Lottspeich F; Ries C; Petrides PE Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672 [TBL] [Abstract][Full Text] [Related]
16. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo. Breckon JJ; Hembry RM; Reynolds JJ; Meikle MC Anat Rec; 1995 Jun; 242(2):177-87. PubMed ID: 7668402 [TBL] [Abstract][Full Text] [Related]
18. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel. Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431 [TBL] [Abstract][Full Text] [Related]
19. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. Deten A; Hölzl A; Leicht M; Barth W; Zimmer HG J Mol Cell Cardiol; 2001 Jun; 33(6):1191-207. PubMed ID: 11444923 [TBL] [Abstract][Full Text] [Related]
20. Is collagenase (matrix metalloproteinase-1) necessary for bone and other connective tissue remodeling? Krane SM Clin Orthop Relat Res; 1995 Apr; (313):47-53. PubMed ID: 7641497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]